Related Experiment Video
Updated: Jun 17, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Correlations between progression of coronary artery disease and circulating endothelial progenitor cells
Carlo Briguori1, Ugo Testa, Roberta Riccioni
1Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy. carlobriguori@clinicamediterranea.it
Insights
Low levels of circulating endothelial progenitor cells (EPCs) predict coronary artery disease (CAD) progression. This finding highlights EPCs as potential biomarkers for monitoring CAD development in patients with non-significant stenosis.
Area of Science:
- Cardiovascular Medicine
- Cell Biology
- Regenerative Medicine
Background:
- The progression of coronary artery disease (CAD) remains incompletely understood.
- Endothelial progenitor cells (EPCs) are implicated in vascular repair and may play a role in CAD pathophysiology.
Purpose of the Study:
- To investigate the relationship between circulating endothelial progenitor cell (EPC) levels and the 24-month progression of non-significant coronary artery lesions.
- To identify predictors of CAD progression in patients undergoing percutaneous coronary intervention.
Main Methods:
- An observational cohort study involving 136 patients with non-significant coronary artery stenosis (<50% diameter stenosis).
- Analysis of circulating EPC populations including CD34(+), CD133(+), CD34(+)/KDR(+), CD34(+)/VE cadherin(+), and endothelial cell colony-forming units (CFU-ECs).
- Coronary angiography was used to assess lesion progression (>15% diameter stenosis increase) at 24 months.
Main Results:
- Significant CAD progression was observed in 42% of patients (57 out of 136) at 24 months.
- Independent predictors of progression included elevated LDL cholesterol (>100 mg/dl), male sex, and low plasma levels of CFU-ECs.
- Patients with angiographic CAD progression exhibited significantly lower circulating EPC levels.
Conclusions:
- Circulating EPC levels, particularly CFU-ECs, are significantly lower in patients experiencing CAD progression.
- Low EPC levels, elevated LDL cholesterol, and male sex are associated with increased risk of coronary artery lesion progression.
- EPCs may serve as valuable biomarkers for predicting CAD progression in individuals with existing coronary artery disease.
Abstract:
The pathophysiology of coronary artery disease (CAD) progression is not well understood. Endothelial progenitor cells (EPCs) may have an important role. In the present observational cohort study we assessed the number of circulating EPCs in 136 patients undergoing elective percutaneous coronary intervention and who had at least one major epicardial vessel with a nonsignificant stenosis [<50% diameter stenosis (DS)], and the relationship between plasma EPC levels and the 24-mo progression of the nonsignificant coronary artery lesion. The following cell populations were analyzed: CD34(+), CD133(+), CD34(+)/KDR(+), CD34(+)/VE cadherin(+), and endothelial cell colony-forming units (CFU-ECs). Progression was defined as a >15% DS increase of the objective vessel at follow-up. At 24 mo, 57 patients (42%) experienced significant progression. Independent predictors of disease progression were LDL cholesterol > 100 mg/dl (OR=1.03; 95% CI 1.01-1.04; P=0.001), low plasma levels of CFU-ECs (OR=3.99; 95% CI 1.54-10.37; P=0.005), and male sex (OR=3.42; 95% CI 1.15-10.22; P=0.027). Circulating levels of EPCs are significantly lower in patients with angiographic CAD progression.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Peripheral Artery Disease I: Introduction